Literature DB >> 34127719

Increases in adipose tissue and muscle function are longitudinally associated with better quality of life in colorectal cancer survivors.

Marlou-Floor Kenkhuis1, Eline H van Roekel2, Janna L Koole2, José J L Breedveld-Peters2, Stéphanie O Breukink3, Maryska L G Janssen-Heijnen2,4, Eric T P Keulen5, Fränzel J B van Duijnhoven6, Floortje Mols7, Matty P Weijenberg2, Martijn J L Bours2.   

Abstract

Colorectal cancer (CRC) survivors need evidence-based guidelines pertaining to post-treatment body composition, which could benefit health-related quality of life (HRQoL). We aimed to describe the course of several body composition measures, and to assess longitudinal associations of these measures with HRQoL, fatigue and chemotherapy-induced peripheral neuropathy (CIPN). In a prospective cohort among stage I-III CRC survivors (n = 459), five repeated home visits from diagnosis up to 24 months post-treatment were executed. Body mass index (BMI), waist circumference and fat percentage were assessed as measures of adiposity, and muscle arm circumference and handgrip strength as measures of muscle mass and function. We applied linear mixed-models to describe changes in body composition over time and to analyze overall longitudinal associations. Of included participants, 44% was overweight and 31% was obese at diagnosis. All body composition measures followed similar trends, decreasing from diagnosis to 6 weeks and then increasing up to 24 months post-treatment. In confounder-adjusted mixed models, increases in adipose tissue and muscle function were longitudinally associated with better HRQoL and less fatigue, regardless of pre-treatment body composition. With regards to improving HRQoL, decreasing fatigue and CIPN, clinical practice should also focus on restoring body tissues after CRC treatment.Trial registration: NTR7099.

Entities:  

Year:  2021        PMID: 34127719     DOI: 10.1038/s41598-021-91709-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  Surviving chemotherapy for colon cancer and living with the consequences.

Authors:  Cindy Tofthagen
Journal:  J Palliat Med       Date:  2010-11       Impact factor: 2.947

2.  The Impact of Body Mass Index and Waist Circumference on Health-related Quality of Life Among Colorectal Cancer Survivors: Results from the PROFILES Registry.

Authors:  Pauline A J Vissers; Renata B Martucci; Floortje Mols; Martijn J L Bours; Renate M Winkels; Ellen Kampman; Matty P Weijenberg; Lonneke V van de Poll-Franse; Sandra Beijer
Journal:  Nutr Cancer       Date:  2017-10-16       Impact factor: 2.900

3.  Lifestyle factors and health-related quality of life in colorectal cancer survivors.

Authors:  Sabrina Schlesinger; Jessica Walter; Jochen Hampe; Witigo von Schönfels; Sebastian Hinz; Thomas Küchler; Gunnar Jacobs; Clemens Schafmayer; Ute Nöthlings
Journal:  Cancer Causes Control       Date:  2013-10-25       Impact factor: 2.506

4.  Global estimates of cancer prevalence for 27 sites in the adult population in 2008.

Authors:  Freddie Bray; Jian-Song Ren; Eric Masuyer; Jacques Ferlay
Journal:  Int J Cancer       Date:  2012-07-26       Impact factor: 7.396

5.  Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.

Authors:  Floortje Mols; Tonneke Beijers; Valery Lemmens; Corina J van den Hurk; Gerard Vreugdenhil; Lonneke V van de Poll-Franse
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Background noise: the experience of chemotherapy-induced peripheral neuropathy.

Authors:  Marie A Bakitas
Journal:  Nurs Res       Date:  2007 Sep-Oct       Impact factor: 2.381

8.  Muscle mass as a target to reduce fatigue in patients with advanced cancer.

Authors:  Elisabeth C W Neefjes; Renske M van den Hurk; Susanne Blauwhoff-Buskermolen; Maurice J D L van der Vorst; Annemarie Becker-Commissaris; Marian A E de van der Schueren; Laurien M Buffart; Henk M W Verheul
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-06-21       Impact factor: 12.910

9.  Associations of adipose and muscle tissue parameters at colorectal cancer diagnosis with long-term health-related quality of life.

Authors:  Eline H van Roekel; Martijn J L Bours; Malou E M Te Molder; José J L Breedveld-Peters; Steven W M Olde Damink; Leo J Schouten; Silvia Sanduleanu; Geerard L Beets; Matty P Weijenberg
Journal:  Qual Life Res       Date:  2017-03-17       Impact factor: 4.147

10.  Quality of Life and Mortality of Long-Term Colorectal Cancer Survivors in the Seattle Colorectal Cancer Family Registry.

Authors:  Scott V Adams; Rachel Ceballos; Polly A Newcomb
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

View more
  2 in total

1.  Longitudinal associations of fiber, vegetable, and fruit intake with quality of life and fatigue in colorectal cancer survivors up to 24 months posttreatment.

Authors:  Marlou-Floor Kenkhuis; Fränzel J B van Duijnhoven; Eline H van Roekel; José J L Breedveld-Peters; Stéphanie O Breukink; Maryska L Janssen-Heijnen; Eric T P Keulen; Floortje Mols; Matty P Weijenberg; Martijn J L Bours
Journal:  Am J Clin Nutr       Date:  2022-03-04       Impact factor: 7.045

2.  Longitudinal Associations of Adherence to the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Lifestyle Recommendations with Quality of Life and Symptoms in Colorectal Cancer Survivors up to 24 Months Post-Treatment.

Authors:  Marlou-Floor Kenkhuis; Floortje Mols; Eline H van Roekel; José J L Breedveld-Peters; Stéphanie O Breukink; Maryska L G Janssen-Heijnen; Eric T P Keulen; Fränzel J B van Duijnhoven; Matty P Weijenberg; Martijn J L Bours
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.